
Yong D. Pak
Examiner (ID: 7339, Phone: (571)272-0935 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1684 |
| Issued Applications | 984 |
| Pending Applications | 234 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19389763
[patent_doc_number] => 20240279633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => PROTEASE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/598872
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18598872
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/598872 | PROTEASE COMPOSITIONS AND METHODS OF USE THEREOF | Mar 6, 2024 | Abandoned |
Array
(
[id] => 19556778
[patent_doc_number] => 20240368570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => LACHNOSPIRACEAE SP. CAS12A MUTANTS WITH ENHANCED CLEAVAGE ACTIVITY AT NON-CANONICAL TTTT PROTOSPACER ADJACENT MOTIFS
[patent_app_type] => utility
[patent_app_number] => 18/590655
[patent_app_country] => US
[patent_app_date] => 2024-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18590655
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/590655 | None | Feb 27, 2024 | Issued |
Array
(
[id] => 19345505
[patent_doc_number] => 20240254468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => RECOMBINANT YEAST HOST CELL EXPRESSING AN HYDROLASE
[patent_app_type] => utility
[patent_app_number] => 18/587167
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587167 | RECOMBINANT YEAST HOST CELL EXPRESSING AN HYDROLASE | Feb 25, 2024 | Pending |
Array
(
[id] => 19203101
[patent_doc_number] => 20240175000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => FEED COMPOSITION SUPPLEMENTED WITH A PROTEASE COMBINATION
[patent_app_type] => utility
[patent_app_number] => 18/436552
[patent_app_country] => US
[patent_app_date] => 2024-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/436552 | FEED COMPOSITION SUPPLEMENTED WITH A PROTEASE COMBINATION | Feb 7, 2024 | Abandoned |
Array
(
[id] => 19345500
[patent_doc_number] => 20240254463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => ENGINEERED STABLE NUCLEIC ACID-GUIDED NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 18/424815
[patent_app_country] => US
[patent_app_date] => 2024-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424815
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424815 | ENGINEERED STABLE NUCLEIC ACID-GUIDED NUCLEASES | Jan 27, 2024 | Abandoned |
Array
(
[id] => 19234027
[patent_doc_number] => 20240191219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => LIQUID FORMULATION OF ALPHA-AMYLASE
[patent_app_type] => utility
[patent_app_number] => 18/411153
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411153
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411153 | LIQUID FORMULATION OF ALPHA-AMYLASE | Jan 11, 2024 | Abandoned |
Array
(
[id] => 20093681
[patent_doc_number] => 20250223617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHOD FOR SYNTHESIZING POLY(3-HYDROXYBUTYRATE) FROM CRUDE GLYCEROL BY USING ESCHERICHIA COLI
[patent_app_type] => utility
[patent_app_number] => 18/409253
[patent_app_country] => US
[patent_app_date] => 2024-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18409253
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/409253 | METHOD FOR SYNTHESIZING POLY(3-HYDROXYBUTYRATE) FROM CRUDE GLYCEROL BY USING ESCHERICHIA COLI | Jan 9, 2024 | Pending |
Array
(
[id] => 19127505
[patent_doc_number] => 20240132858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => ENGINEERED URIDINE PHOSPHORYLASE VARIANT ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/403265
[patent_app_country] => US
[patent_app_date] => 2024-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18403265
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/403265 | Engineered uridine phosphorylase variant enzymes | Jan 2, 2024 | Issued |
Array
(
[id] => 19158036
[patent_doc_number] => 20240150743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => SUBTILASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
[patent_app_type] => utility
[patent_app_number] => 18/401373
[patent_app_country] => US
[patent_app_date] => 2023-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18401373
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/401373 | SUBTILASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | Dec 29, 2023 | Pending |
Array
(
[id] => 19127221
[patent_doc_number] => 20240132574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => MULTISTEP FINAL FILTRATION
[patent_app_type] => utility
[patent_app_number] => 18/389809
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18389809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/389809 | MULTISTEP FINAL FILTRATION | Dec 19, 2023 | Pending |
Array
(
[id] => 19127221
[patent_doc_number] => 20240132574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => MULTISTEP FINAL FILTRATION
[patent_app_type] => utility
[patent_app_number] => 18/389809
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18389809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/389809 | MULTISTEP FINAL FILTRATION | Dec 19, 2023 | Pending |
Array
(
[id] => 19361124
[patent_doc_number] => 20240263158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => DUPLEX-SPECIFIC DNASES
[patent_app_type] => utility
[patent_app_number] => 18/390303
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18390303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/390303 | DUPLEX-SPECIFIC DNASES | Dec 19, 2023 | Pending |
Array
(
[id] => 19051203
[patent_doc_number] => 20240093172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => Compositions Comprising Polypeptides Having Mannanase Activity
[patent_app_type] => utility
[patent_app_number] => 18/517607
[patent_app_country] => US
[patent_app_date] => 2023-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18517607
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/517607 | Compositions Comprising Polypeptides Having Mannanase Activity | Nov 21, 2023 | Pending |
Array
(
[id] => 19020476
[patent_doc_number] => 20240076647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => ENGINEERED DEOXYRIBOSE-PHOSPHATE ALDOLASES
[patent_app_type] => utility
[patent_app_number] => 18/503542
[patent_app_country] => US
[patent_app_date] => 2023-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18503542
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/503542 | Engineered deoxyribose-phosphate aldolases | Nov 6, 2023 | Issued |
Array
(
[id] => 20129376
[patent_doc_number] => 12371680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Terminal deoxynucleotidyl transferase variants and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/504010
[patent_app_country] => US
[patent_app_date] => 2023-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10159
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18504010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/504010 | Terminal deoxynucleotidyl transferase variants and uses thereof | Nov 6, 2023 | Issued |
Array
(
[id] => 19020475
[patent_doc_number] => 20240076646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => SYSTEM AND METHOD OF OPTOGENETICALLY CONTROLLING METABOLIC PATHWAYS FOR THE PRODUCTION OF CHEMICALS
[patent_app_type] => utility
[patent_app_number] => 18/502266
[patent_app_country] => US
[patent_app_date] => 2023-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18502266
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/502266 | SYSTEM AND METHOD OF OPTOGENETICALLY CONTROLLING METABOLIC PATHWAYS FOR THE PRODUCTION OF CHEMICALS | Nov 5, 2023 | Pending |
Array
(
[id] => 19034466
[patent_doc_number] => 20240084281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => VARIANTS OF CHYMOSIN WITH IMPROVED MILK-CLOTTING PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 18/497758
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497758
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497758 | VARIANTS OF CHYMOSIN WITH IMPROVED MILK-CLOTTING PROPERTIES | Oct 29, 2023 | Pending |
Array
(
[id] => 19158039
[patent_doc_number] => 20240150746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => USE OF GLUTAMINE SYNTHETASE FOR TREATING HYPERAMMONEMIA
[patent_app_type] => utility
[patent_app_number] => 18/497740
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497740 | USE OF GLUTAMINE SYNTHETASE FOR TREATING HYPERAMMONEMIA | Oct 29, 2023 | Pending |
Array
(
[id] => 19020472
[patent_doc_number] => 20240076643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => MODIFIED L-ASPARAGINASE
[patent_app_type] => utility
[patent_app_number] => 18/471899
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18471899
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/471899 | MODIFIED L-ASPARAGINASE | Sep 20, 2023 | Pending |
Array
(
[id] => 19738540
[patent_doc_number] => 12215360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
[patent_app_type] => utility
[patent_app_number] => 18/465961
[patent_app_country] => US
[patent_app_date] => 2023-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 8768
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18465961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/465961 | Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith | Sep 11, 2023 | Issued |